Cirrhosis, Hepatic Encephalopathy, and Ammonium Toxicity

Front Matter....Pages i-viii
Cerebral Function in Hepatic Encephalopathy....Pages 1-22
Ammonia Metabolism in Normal and Portacaval-Shunted Rats....Pages 23-46
Nitrogen Metabolism in Normal and Cirrhotic Liver....Pages 47-64
Hyperammonemia Induces Brain Tubulin....Pages 65-80
Astrocytes in Hepatic Encephalopathy....Pages 81-97
Effects of NH 4 + on the Function of the CNS....Pages 99-120
Hepatic Encephalopathy, GABA-ergic Neurotransmission and Benzodiazepine Receptor Ligands....Pages 121-134
Neurotransmission in Hepatic Encephalopathy....Pages 135-148
Synaptic Plasma Membrane Composition and Fluidity in the Pathogenesis of Hepatic Encephalopathy....Pages 149-157
Metabolic Effects of Carnitine and Carnitine Analogs....Pages 159-174
Clinical Use of Carnitine Past, Present and Future....Pages 175-181
New Roles of Carnitine Metabolism in Ammonia Cytotoxicity....Pages 183-195
Effect of L-Carnitine Upon Ammonia Tolerance Test in Cirrhotic Patients....Pages 197-208
Metabolism of Sedatives in Liver Disease....Pages 209-226
Branched Chain Amino Acids in the Treatment of Hepatic Encephalopathy....Pages 227-233
Treatment of Portal Systemic Encephalopathy: The Old and New Treatments....Pages 235-253
Benzodiazepine Antagonist in the Treatment of Human Hepatic Encephalopathy....Pages 255-265
Back Matter....Pages 267-276